Outlook Therapeutics Ownership | Who Owns Outlook Therapeutics?


OverviewForecastRevenueFinancialsChartTranscripts

Outlook Therapeutics Ownership Summary


Outlook Therapeutics is owned by 79.54% institutional investors, 12.64% insiders, and 7.82% retail investors. Vanguard group is the largest institutional shareholder, holding 4.21% of OTLK shares. Vanguard MStar Total Stk Mkt Idx Invest is the top mutual fund, with 4.75% of its assets in Outlook Therapeutics shares.

OTLK Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockOutlook Therapeutics79.54%12.64%7.82%
SectorHealthcare Stocks 244.59%12.11%-156.70%
IndustryBiotech Stocks 379.61%11.70%-291.31%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group1.47M4.21%$2.31M
Geode capital management603.61K1.00%$124.23K
Blackrock funding, inc. /de477.47K0.79%$98.26K
Vanguard fiduciary trust176.53K0.29%$36.37K
State street163.10K0.27%$33.57K
Susquehanna group, llp134.08K0.22%$27.59K
Ubs group133.07K0.22%$27.41K
Simplex trading132.67K0.22%$27.30M
Group one trading113.70K0.19%$23.40K
Hrt financial lp67.76K0.11%$13.00K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Two sigma securities35.66K0.01%$37.80K
Christensen, king & associates investment services28.33K0.00%$5.83K
Flower city capital20.00K0.00%$4.12K
Point72 asia (singapore) pte.5.82K0.00%$6.16K
Fortitude family office2.55K0.00%$526.00
Vanguard personalized indexing management31.49K0.00%$6.48K
Tower research capital llc (trc)14.80K0.00%$3.05K
Renaissance---
Legal & general group---
Geode capital management603.61K-$124.23K

Top Buyers

HolderShares% AssetsChange
Geode capital management603.61K-287.14K
Vanguard fiduciary trust176.53K-176.53K
Vanguard group1.47M-122.54K
Group one trading113.70K-76.70K
Blackrock funding, inc. /de477.47K-72.93K

Top Sellers

HolderShares% AssetsChange
Armistice capital---4.17M
Schonfeld strategic advisors---2.44M
Sphera funds management---857.14K
Commonwealth equity services---470.00K
Rosalind advisors---450.00K

New Positions

HolderShares% AssetsChangeValue
Vanguard fiduciary trust176.53K-176.53K$36.37K
Hrt financial lp67.76K-67.76K$13.00K
Two sigma securities35.66K0.01%35.66K$37.80K
Ci private wealth30.10K-30.10K$6.20K
Raymond james financial27.05K-27.05K$5.57K

Sold Out

HolderChange
Barclays-1.00
True wealth design-20.00
Ifp advisors-50.00
Corecap advisors-62.00
Tradewinds capital management-100.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20267832.20%20,263,42388.92%794.49%5159.38%7-
Mar 31, 202659-3.28%10,725,39157.24%1713.88%32-814.29%
Dec 31, 202513-77.59%1,856,635-54.47%54.38%7-69.57%--100.00%
Sep 30, 202516-73.77%1,609,381-69.77%41.46%8-75.00%4-75.00%
Jun 30, 2025641.59%5,935,574-16.22%193.65%33-13.16%1838.46%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard MStar Total Stk Mkt Idx Invest3.07M4.75%-
Vanguard Total Stock Mkt Idx Inv3.07M2.07%2.13M
Vanguard Institutional Extnd Mkt Idx Tr1.23M1.91%-
Vanguard Morn Total Stk Mkt Idx Investor3.07M1.64%2.13M
Vanguard US Total Market Shares ETF442.51K1.38%-
CREF Stock R1100.34K0.42%65.13K
Fidelity Small Cap Index169.90K0.40%-6.23K
Federated Hermes MDT Small Cap Growth IS88.30K0.37%88.30K
Federated Hermes MDT SCG Institutional88.30K0.37%88.30K
Fidelity Extended Market Index551.08K0.29%168.40K

Recent Insider Transactions


DateNameRoleActivityValue
Aug 14, 2026Jahr Robert Charles Chief Executive OfficerBuy$150.00K
Aug 14, 2026Jahr Robert Charles Chief Executive OfficerBuy$166.67K
Aug 12, 2026Sukhtian Ghiath M. Buy$2.78M
Aug 12, 2026Sukhtian Ghiath M. Buy$2.50M
Aug 14, 2026KENYON LAWRENCE A Chief Financial OfficerBuy$100.00K

Insider Transactions Trends


DateBuySell
2026 Q37-
2026 Q28-
2025 Q4--
2025 Q3--
2025 Q2--

OTLK Ownership FAQ


Who Owns Outlook Therapeutics?

Outlook Therapeutics shareholders are primarily institutional investors at 79.54%, followed by 12.64% insiders and 7.82% retail investors. The average institutional ownership in Outlook Therapeutics's industry, Biotech Stocks , is 379.61%, which Outlook Therapeutics falls below.

Who owns the most shares of Outlook Therapeutics?

Outlook Therapeutics’s largest shareholders are Vanguard group (1.47M shares, 4.21%), Geode capital management (603.61K shares, 1.00%), and Blackrock funding, inc. /de (477.47K shares, 0.79%). Together, they hold 6.01% of Outlook Therapeutics’s total shares outstanding.

Does Blackrock own Outlook Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Outlook Therapeutics.

Who is Outlook Therapeutics’s biggest shareholder by percentage of total assets invested?

Two sigma securities is Outlook Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.01% of its assets in 35.66K Outlook Therapeutics shares, valued at 37.8K$.

Who is the top mutual fund holder of Outlook Therapeutics shares?

Vanguard MStar Total Stk Mkt Idx Invest is the top mutual fund holder of Outlook Therapeutics shares, with 4.75% of its total shares outstanding invested in 3.07M Outlook Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools